MANE

MANE remains in a robust uptrend, reflected by active higher highs and lows above rising EMAs, with price consolidating near the 9EMA/20EMA zone without signs of exhaustion. Long- and medium-term biases are bullish, and short-term EMAs are tracking higher, supporting immediate buy readiness. Execution is now warranted on shallow pullbacks into the rising EMA support area for continuation participation.

• ↑Phase 2/3 topline: VDPHL01 drives significant hair growth vs placebo.
• ↑Cash reserves at $819.9 M fund R&D and ops through 2030.
• ↓Q2 net loss of $23.5 M ($0.58/sh) raises profitability concerns.